Rapt Therapeutics Share Price Today
(NASDAQ: RAPT)

Name: Rapt Therapeutics Share Price Today (NASDAQ: RAPT) - Rapt Therapeutics Stock Price Live Quote | INDmoney
Brand: INDmoney
Rating: 4.7 (371551 reviews)

Rapt Therapeutics share price is $1.31 & ₹112.69 as on 22 Mar 2025, 2.30 'hrs' IST

$1.31

▲

0.11

(9.17%)

Market is closed - opens 7 PM, 24 Mar 2025

View live Rapt Therapeutics share price in Dollar and Rupees. Guide to invest in Rapt Therapeutics stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Rapt Therapeutics, along with analyst recommendations, forecasts, and comprehensive financials.

Rapt Therapeutics share price movements

Today's Low: $1.17
Today's High: $1.33
$1.31
11.07%
Downside
Day's Volatility :12.41%
Upside
1.5%
52 Weeks Low: $0.79
52 Weeks High: $9.65
$1.31
39.75%
Downside
52 Weeks Volatility :91.82%
Upside
86.43%

Rapt Therapeutics (RAPT) Returns

Period	Rapt Therapeutics Inc	Sector (Health Care)	Index (Russel 2000)
3 Months	-24.71%	5.2%	0.0%
6 Months	-25.57%	-4.9%	0.0%
1 Year	-84.16%	0.8%	0.0%
3 Years	-94.07%	8.1%	-14.8%

Rapt Therapeutics (RAPT) Key Statistics

in dollars & INR

Previous Close	$1.2
Open	$1.18
Today's High	$1.33
Today's Low	$1.165
Market Capitalization	$172.9M
Today's Volume	$4.7M
52 Week High	$9.6536
52 Week Low	$0.78925
Revenue TTM	$0.0
EBITDA	$-134.9M
Earnings Per Share (EPS)	$-3.19
Profit Margin	0.0%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-77.09%

How to invest in Rapt Therapeutics Stock (RAPT) from India?

It is very easy for Indian residents to invest directly in Rapt Therapeutics from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Rapt Therapeutics stock in both Indian Rupees (INR) and US Dollars (USD). Search for Rapt Therapeutics or RAPT on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Rapt Therapeutics or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Rapt Therapeutics shares which would translate to 0.657 fractional shares of Rapt Therapeutics as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Rapt Therapeutics, in just a few clicks!

Returns in Rapt Therapeutics (RAPT) for Indian investors in Rupees

The Rapt Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

Rapt Therapeutics investment value today

Current value as on today

₹19,078

Returns

₹80,922

(-80.92%)

Returns from Rapt Therapeutics Stock

₹84,160 (-84.16%)

Dollar Returns

₹3,238 (+3.24%)

Indian investors sentiment towards Rapt Therapeutics (RAPT)

-49%

Period: Feb 21, 2025 to Mar 23, 2025. Change in 30 Days versus previous period

Search interest for Rapt Therapeutics Stock from India on INDmoney has decreased by -49% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Rapt Therapeutics

Orbimed Advisors, LLC
9.95%
TCG Crossover Management, LLC
9.95%
Foresite Capital Management VI LLC
9.47%
RTW INVESTMENTS, LLC
8.91%
Bvf Inc
7.00%
Redmile Group, LLC
4.91%

Analyst Recommendation on Rapt Therapeutics

Buy

64%Buy

35%Hold

0%Sell

Based on 17 Wall street analysts offering stock ratings for Rapt Therapeutics(by analysts ranked 0 to 5 stars)

Based on 17 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Rapt Therapeutics Stock (RAPT)

What analysts predicted

Upside of 281.68%

Target:

$5.00

Current:

$1.31

Insights on Rapt Therapeutics Stock (Ticker Symbol: RAPT)

Price Movement
In the last 7 days, RAPT stock has moved up by 17.0%
RAPT vs ALNY (1 yr)
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 93.4% return, outperforming this stock by 177.7%
RAPT vs VRTX (3 yr)
In the last 3 years, Vertex Pharmaceuticals Incorporated has given 73.1% return, outperforming this stock by 167.5%

Rapt Therapeutics Technicals Summary

Sell

Neutral

Buy

Rapt Therapeutics is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Rapt Therapeutics (RAPT) Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Rapt Therapeutics Inc	11.02%	-25.57%	-84.16%	-94.07%	-92.14%
Regeneron Pharmaceuticals, Inc.	-7.68%	-39.7%	-31.49%	-3.17%	53.21%
Beone Medicines Ltd	-2.52%	25.17%	63.71%	30.82%	106.81%
Vertex Pharmaceuticals Incorporated	4.47%	9.39%	20.95%	98.15%	139.52%
Alnylam Pharmaceuticals, Inc.	13.82%	4.23%	86.32%	72.97%	186.84%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Rapt Therapeutics Inc	NA	NA	NA	-0.6	-0.77	-0.41	NA	1.44
Regeneron Pharmaceuticals, Inc.	17.18	17.18	0.98	42.64	0.16	0.07	0.01	273.57
Beone Medicines Ltd	NA	NA	NA	1.45	-0.19	-0.06	NA	31.22
Vertex Pharmaceuticals Incorporated	32.84	NA	1.43	18.06	-0.03	0.13	NA	63.87
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	0.71	-15.01	-0.03	NA	0.52

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Rapt Therapeutics Inc	Buy	$172.9M	-92.14%	NA	0.0%
Regeneron Pharmaceuticals, Inc.	Buy	$72.0B	53.21%	17.18	31.07%
Beone Medicines Ltd	NA	$29.2B	106.81%	NA	-16.92%
Vertex Pharmaceuticals Incorporated	Buy	$129.2B	139.52%	32.84	-4.86%
Alnylam Pharmaceuticals, Inc.	Buy	$36.7B	186.84%	NA	-12.37%

About Rapt Therapeutics

RAPT Therapeutics, Inc., a clinical-stage immunology-based biopharmaceutical company, focuses on discovery, development, and commercialization of oral small molecule therapies for patients with unmet needs in oncology and inflammatory diseases in the United States. The company's lead inflammation drug candidate is zelnecirnon (RPT193), a C-C motif chemokine receptor 4 (CCR4) antagonist that selectively inhibit the migration of type 2 T helper cells into inflamed tissues. Its lead oncology drug candidate is tivumecirnon (FLX475), an oral small molecule CCR4 antagonist that is in the Phase 1/2 clinical trial to investigate as a monotherapy and in combination with pembrolizumab in patients with advanced cancer. The company was formerly known as FLX Bio, Inc. and changed its name to RAPT Therapeutics, Inc. in May 2019. RAPT Therapeutics, Inc. was incorporated in 2015 and is headquartered in South San Francisco, California.

Organization	Rapt Therapeutics
Employees	68
CEO	Dr. Brian Russell Wong M.D., Ph.D.
Industry	Health Technology

Management People of Rapt Therapeutics

Name	Title
Dr. Brian Russell Wong M.D., Ph.D.	CEO, President & Director
Mr. Rodney K. B. Young	CFO, Principal Accounting Officer & Secretary
Dr. William Ho M.D., Ph.D.	Chief Medical Officer
Steve Young Ph.D.	Vice President of Technology
Dr. Dirk G. Brockstedt Ph.D.	Chief Scientific Officer
Mr. Michael Listgarten	General Counsel
Ms. Gwen R. Carscadden	Chief Human Resources Officer
Dr. Paul Kassner Ph.D.	Senior Vice President of Biology
Ms. Jennifer Nicholson	Senior Vice President of Regulatory Affairs & Quality Assurance
Dr. Nipun Davar MBA, Ph.D.	Senior Vice President of Technical Operations

Important FAQs about investing in RAPT Stock from India :

What is Rapt Therapeutics share price today?

Rapt Therapeutics share price today stands at $1.31, Open: $1.18 ; Previous Close: $1.20 ; High: $1.33 ; Low: $1.17 ; 52 Week High: $9.65 ; 52 Week Low: $0.79.

The stock opens at $1.18, after a previous close of $1.20. The stock reached a daily high of $1.33 and a low of $1.17, with a 52-week high of $9.65 and a 52-week low of $0.79.

Can Indians buy Rapt Therapeutics shares?

Yes, Indians can invest in the Rapt Therapeutics (RAPT) from India.

With INDmoney, you can buy Rapt Therapeutics at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Rapt Therapeutics at zero transaction cost.

How can I buy Rapt Therapeutics shares from India?

It is very easy to buy Rapt Therapeutics from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Rapt Therapeutics (RAPT) be purchased?

Yes, you can buy fractional shares of Rapt Therapeutics with INDmoney app.

What are the documents required to start investing in Rapt Therapeutics stocks?

To start investing in Rapt Therapeutics, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.